The Severity of Symptoms Related to Irritable Bowel Syndrome is a Risk Factor for the Misclassification of Significant Organic Disease
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Background and Aims: The diagnosis of irritable bowel syndrome (IBS) is based mainly on clinical evaluation. The reported incidence of misclassification of significant organic diseases in previously diagnosed IBS patients differs between studies. The aim of this study was to examine the incidence and risk factors for the misclassification of significant organic disease [colon cancer, inflammatory bowel disease (IBD), Celiac disease, and thyroid dysfunction] in a cohort of young patients with symptoms attributed to IBS. Methods: In this population-based cohort study, we examined the incidence and risk factors for the diagnosis of a new significant organic diseases in a cohort of 2645 IBS patients. Results: During follow-up, organic disease was diagnosed in 27 subjects (1.03%): IBD in 23, Celiac disease in 2, IBD and Celiac disease in 1, and hypothyroidism in1. The mean interval from the diagnosis of IBS to the diagnosis of an organic disorder was 13.08±8.51 months. Increased symptom severity was the only significant risk factor for the misclassification of an organic disease (hazard ratio, 2.26; 95% confidence interval, 1.01-5.05; P=0.047). The risk ratio for misclassification of organic diseases in moderate to severe IBS was increased by 2.575 (95% confidence interval, 1.10-6.51; P=0.027) as compared with mild IBS. Conclusions: The incidence of misclassification of major organic disease in IBS patients was low. Increased symptoms severity was the only significant risk factor for the misclassification of organic disorders. Further gastrointestinal evaluation should be considered in patients with moderate to severe symptoms attributed to IBS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the risk of missing, or subsequently developing, an organic disorder in patients diagnosed with IBS is low, this rate may be increased in those with severe symptoms, 267”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [267]
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
High body mass index for age among US children and adolescents, 2003-2006.
Ogden, C. L. (2008) · JAMA · doi:10.1001/jama.299.20.2401 · Cited by 1,850
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome
American College of Gastroenterology IBS Task Force (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.122 · Cited by 694
US Preventive Services Task Force (2010) · Pediatrics · doi:10.1542/peds.2009-2037 · Cited by 617
Halpin, S. J., & Ford, A. C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.260 · Cited by 607
Costs of Irritable Bowel Syndrome in the UK and US
Maxion-Bergemann, S., Thielecke, F., Abel, F., & Bergemann, R. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624010-00002 · Cited by 263
The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review
Cash, B. D., Schoenfeld, P., & Chey, W. D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07027.x · Cited by 240
Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report
Drossman, D. A., Chang, L., Bellamy, N., Gallo-Torres, H. E., Lembo, A., Mearin, F., Norton, N. J., & Whorwell, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.201 · Cited by 226
Saito, Y. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01985-7 · Cited by 225
Cited by
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
Alexithymia in Gastroenterology and Hepatology: A Systematic Review
Carrozzino, D., & Porcelli, P. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00470 · Cited by 54
“These overlapping IBD-IBS symptoms represent a source of considerable psychological distress for IBD patients, as well as a diagnostic and therapeutic conundrum for the physician (Stanisic and Quigley, 2014; Carter et al., 2017).”
BackgroundKhasawneh, M., Craig, O. F., Gracie, D. J., Black, C. J., & Ford, A. C. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.05.022 · Cited by 24
He, Y.-Q., Tan, Y. H., Zhu, J.-R., Wu, X., Huang, Z., Chen, H., Yang, M., & Chen, D. (2021) · Bioengineered · doi:10.1080/21655979.2021.1920324 · Cited by 12
“The main symptoms of IBS are chronic and intermittent gastrointestinal dysfunction [3,4].”
BackgroundNorwood, D. A., Dominguez, L. B., Paredes, A. A., Montalvan-Sanchez, E. E., Rodriguez-Murillo, A. A., Dougherty, M., Palsson, O. S., Domínguez, R. L., & Morgan, D. R. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06639-y · Cited by 13
“They are often under- or mis-diagnosed [13], and their impact is underestimated due to low mortality rates [14, 15], despite a well-documented impact on quality of life [16–18] and high economic burden due to healthcare expenditures and indirect costs (e.”
Background
Metadata
- Authors
- Carter, D., Beer-Gabel, M., Derazne, E., Tzur, D., & Bardan, E.
- Affiliations
- Tel Aviv University (IL)
- Israel Defense Forces Medical Corps (IL)
- Corresponding author
- Carter, Dan
- Derazne, Estela
- Tzur, Dorit
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2017-05
- Volume
- 51
- Issue
- 5
- Pages
- 421-425
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2465261887
- Cited by
- 11
- References
- 34
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 2 · 2021: 2 · 2020: 1 · 2018: 3
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Family Practice › Clinical Reasoning and Diagnostic Skills
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- irritable bowel syndrome, symptom severity, inflammatory bowel disease, celiac disease, colon cancer, hypothyroidism, risk factors, young patients
- MeSH terms
- Adolescent, Adult, Celiac Disease, Colonic Neoplasms, Diagnostic Errors, Female, Humans, Hypothyroidism, Israel, Male, Predictive Value of Tests, Prognosis, Risk Factors, Severity of Illness Index, Time Factors, Incidence, Databases, Factual, Irritable Bowel Syndrome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Severity of Symptoms Related to Irritable Bowel Syndrome is a Risk Factor for the Misclassification of Significant Organic Disease. https://app.cochat.ai/papers/10.1097/mcg.0000000000000582
- The paper
- Carter, D., Beer-Gabel, M., Derazne, E., Tzur, D., & Bardan, E. (2017). The Severity of Symptoms Related to Irritable Bowel Syndrome is a Risk Factor for the Misclassification of Significant Organic Disease. Journal of Clinical Gastroenterology. https://doi.org/10.1097/mcg.0000000000000582
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.